PAVmed Historical Balance Sheet

PAVM Stock

USD 0.94 0.04 4.44%

Trend analysis of PAVmed Inc balance sheet accounts such as Accounts Payable of 1.9 M, Cash of 18.9 M, Cash And Short Term Investments of 18.9 M or Common Stock Total Equity of 103.8 K provides information on PAVmed's total assets, liabilities, and equity, which is the actual value of PAVmed Inc to its prevalent stockholders. By breaking down trends over time using PAVmed balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining PAVmed Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PAVmed Inc is a good buy for the upcoming year.

PAVmed Inventory

512,050

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

About PAVmed Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of PAVmed Inc at a specified time, usually calculated after every quarter, six months, or one year. PAVmed Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of PAVmed and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which PAVmed currently owns. An asset can also be divided into two categories, current and non-current.

PAVmed Balance Sheet Chart

At this time, PAVmed's Other Stockholder Equity is very stable compared to the past year. As of the 28th of November 2024, Total Liabilities is likely to grow to about 60 M, though Total Stockholder Equity is likely to grow to (51.1 M).

Total Assets Accounts Payable Cash And Short Term Investments

Add Fundamental

Total Assets

Total assets refers to the total amount of PAVmed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in PAVmed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Accounts Payable

An accounting item on the balance sheet that represents PAVmed obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of PAVmed Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of PAVmed Inc balance sheet. This account contains PAVmed investments that will expire within one year. These investments include stocks and bonds that can be liquidated by PAVmed Inc fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most accounts from PAVmed's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into PAVmed Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

	2021	2022	2023	2024 (projected)
Cash	77.3M	39.7M	19.6M	18.9M
Accounts Payable	3.3M	2.7M	1.8M	1.9M

Cash Accounts Payable

PAVmed balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Non Current Liabilities Total	Property Plant And Equipment Net	Retained Earnings Total Equity	Property Plant And Equipment Gross	Property Plant Equipment
Total Assets		0.28	0.46	0.3	0.51	-0.58	-0.66	0.77	0.99	0.99	0.78	-0.02	0.8	-0.1	0.79	0.45	1.0	0.79	0.66	0.61	0.41	0.78	0.55	-0.87	0.52	0.54
Other Current Liab	0.28		0.37	-0.27	-0.05	0.07	-0.44	-0.04	0.24	0.24	0.3	0.18	0.42	0.03	0.43	0.37	0.25	-0.16	0.53	0.13	-0.38	0.19	0.56	-0.26	0.56	0.57
Total Current Liabilities	0.46	0.37		-0.69	-0.46	0.44	-0.97	0.55	0.37	0.37	0.89	0.07	0.89	-0.03	0.9	1.0	0.4	0.21	0.91	0.68	-0.08	-0.08	0.95	-0.81	0.96	0.96
Total Stockholder Equity	0.3	-0.27	-0.69		0.89	-0.94	0.51	0.11	0.41	0.41	-0.3	-0.09	-0.31	0.0	-0.32	-0.7	0.38	0.47	-0.47	-0.24	0.47	0.7	-0.61	0.15	-0.64	-0.62
Net Tangible Assets	0.51	-0.05	-0.46	0.89		-0.95	0.23	0.2	0.6	0.6	-0.03	-0.11	-0.01	-0.09	-0.04	-0.47	0.58	0.39	-0.24	-0.1	0.28	0.92	-0.35	-0.08	-0.37	-0.37
Net Debt	-0.58	0.07	0.44	-0.94	-0.95		-0.22	-0.31	-0.67	-0.67	0.01	0.07	-0.01	0.04	0.01	0.45	-0.65	-0.6	0.18	0.03	-0.46	-0.89	0.33	0.15	0.36	0.35
Retained Earnings	-0.66	-0.44	-0.97	0.51	0.23	-0.22		-0.64	-0.58	-0.58	-0.96	-0.04	-0.97	0.06	-0.98	-0.97	-0.6	-0.35	-0.96	-0.74	0.0	-0.16	-0.96	0.91	-0.96	-0.97
Accounts Payable	0.77	-0.04	0.55	0.11	0.2	-0.31	-0.64		0.76	0.76	0.8	0.17	0.73	0.25	0.72	0.54	0.77	0.81	0.52	0.52	0.37	0.47	0.45	-0.86	0.43	0.46
Cash	0.99	0.24	0.37	0.41	0.6	-0.67	-0.58	0.76		1.0	0.73	-0.02	0.74	-0.09	0.73	0.36	1.0	0.8	0.58	0.53	0.42	0.85	0.45	-0.82	0.42	0.44
Cash And Short Term Investments	0.99	0.24	0.37	0.41	0.6	-0.67	-0.58	0.76	1.0		0.73	-0.02	0.74	-0.09	0.73	0.36	1.0	0.8	0.58	0.53	0.42	0.85	0.45	-0.82	0.42	0.44
Common Stock Total Equity	0.78	0.3	0.89	-0.3	-0.03	0.01	-0.96	0.8	0.73	0.73		0.0	0.99	0.0	0.99	0.89	0.75	0.52	0.89	0.75	0.15	0.35	0.86	-0.98	0.86	0.87
Common Stock Shares Outstanding	-0.02	0.18	0.07	-0.09	-0.11	0.07	-0.04	0.17	-0.02	-0.02	0.0		0.02	-0.18	0.02	0.08	-0.02	-0.04	-0.03	-0.44	-0.49	-0.05	0.02	-0.01	0.02	0.01
Capital Surpluse	0.8	0.42	0.89	-0.31	-0.01	-0.01	-0.97	0.73	0.74	0.74	0.99	0.02		-0.07	1.0	0.89	0.76	0.48	0.93	0.73	0.1	0.38	0.91	-0.97	0.9	0.91
Other Current Assets	-0.1	0.03	-0.03	0.0	-0.09	0.04	0.06	0.25	-0.09	-0.09	0.0	-0.18	-0.07		-0.07	-0.03	-0.09	0.11	-0.13	0.14	0.23	-0.07	-0.14	-0.01	-0.14	-0.08
Other Stockholder Equity	0.79	0.43	0.9	-0.32	-0.04	0.01	-0.98	0.72	0.73	0.73	0.99	0.02	1.0	-0.07		0.9	0.75	0.48	0.94	0.73	0.1	0.35	0.92	-0.96	0.91	0.92
Total Liab	0.45	0.37	1.0	-0.7	-0.47	0.45	-0.97	0.54	0.36	0.36	0.89	0.08	0.89	-0.03	0.9		0.39	0.2	0.91	0.67	-0.09	-0.09	0.95	-0.81	0.96	0.96
Total Current Assets	1.0	0.25	0.4	0.38	0.58	-0.65	-0.6	0.77	1.0	1.0	0.75	-0.02	0.76	-0.09	0.75	0.39		0.79	0.6	0.56	0.41	0.83	0.48	-0.84	0.45	0.47
Common Stock	0.79	-0.16	0.21	0.47	0.39	-0.6	-0.35	0.81	0.8	0.8	0.52	-0.04	0.48	0.11	0.48	0.2	0.79		0.37	0.51	0.77	0.54	0.22	-0.67	0.17	0.21
Non Current Assets Total	0.66	0.53	0.91	-0.47	-0.24	0.18	-0.96	0.52	0.58	0.58	0.89	-0.03	0.93	-0.13	0.94	0.91	0.6	0.37		0.75	0.1	0.14	0.98	-0.86	0.97	0.98
Non Currrent Assets Other	0.61	0.13	0.68	-0.24	-0.1	0.03	-0.74	0.52	0.53	0.53	0.75	-0.44	0.73	0.14	0.73	0.67	0.56	0.51	0.75		0.53	0.17	0.69	-0.76	0.68	0.7
Other Assets	0.41	-0.38	-0.08	0.47	0.28	-0.46	0.0	0.37	0.42	0.42	0.15	-0.49	0.1	0.23	0.1	-0.09	0.41	0.77	0.1	0.53		0.26	-0.06	-0.28	-0.1	-0.06
Non Current Liabilities Total	0.78	0.19	-0.08	0.7	0.92	-0.89	-0.16	0.47	0.85	0.85	0.35	-0.05	0.38	-0.07	0.35	-0.09	0.83	0.54	0.14	0.17	0.26		0.03	-0.45	0.01	0.02
Property Plant And Equipment Net	0.55	0.56	0.95	-0.61	-0.35	0.33	-0.96	0.45	0.45	0.45	0.86	0.02	0.91	-0.14	0.92	0.95	0.48	0.22	0.98	0.69	-0.06	0.03		-0.8	1.0	1.0
Retained Earnings Total Equity	-0.87	-0.26	-0.81	0.15	-0.08	0.15	0.91	-0.86	-0.82	-0.82	-0.98	-0.01	-0.97	-0.01	-0.96	-0.81	-0.84	-0.67	-0.86	-0.76	-0.28	-0.45	-0.8		-0.79	-0.8
Property Plant And Equipment Gross	0.52	0.56	0.96	-0.64	-0.37	0.36	-0.96	0.43	0.42	0.42	0.86	0.02	0.9	-0.14	0.91	0.96	0.45	0.17	0.97	0.68	-0.1	0.01	1.0	-0.79		1.0
Property Plant Equipment	0.54	0.57	0.96	-0.62	-0.37	0.35	-0.97	0.46	0.44	0.44	0.87	0.01	0.91	-0.08	0.92	0.96	0.47	0.21	0.98	0.7	-0.06	0.02	1.0	-0.8	1.0

Click cells to compare fundamentals

PAVmed Account Relationship Matchups

PAVmed balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.2M	19.8M	87.0M	54.0M	33.1M	23.6M
Other Current Liab	1.4M	(15.0M)	4.3M	3.7M	6.6M	7.0M
Total Current Liabilities	11.9M	20.0M	7.6M	41.2M	54.2M	56.9M
Total Stockholder Equity	(3.8M)	1.9M	61.7M	(9.7M)	(53.8M)	(51.1M)
Net Tangible Assets	(6.1M)	(641K)	57.2M	(15.8M)	(18.2M)	(17.3M)
Net Debt	1.9M	(2.3M)	(77.3M)	(3.1M)	29.1M	30.5M
Retained Earnings	(53.7M)	(88.3M)	(138.9M)	(228.2M)	(294.4M)	(279.7M)
Accounts Payable	2.4M	3.0M	3.3M	2.7M	1.8M	1.9M
Cash	6.2M	17.3M	77.3M	39.7M	19.6M	18.9M
Cash And Short Term Investments	6.2M	17.3M	77.3M	39.7M	19.6M	18.9M
Common Stock Total Equity	27.1K	40.5K	64K	86K	98.9K	103.8K
Common Stock Shares Outstanding	2.0M	3.2M	5.2M	5.9M	7.2M	6.9M
Liabilities And Stockholders Equity	7.2M	19.8M	87.0M	54.0M	33.1M	23.6M
Capital Surpluse	32.6M	47.6M	87.6M	198.1M	227.8M	239.2M
Other Current Assets	328.3B	1.7M	5.2M	3.9M	3.8M	3.6M
Other Stockholder Equity	47.6M	87.6M	198.1M	215.9M	237.6M	249.5M
Total Liab	11.9M	20.3M	7.6M	43.0M	57.1M	60.0M
Total Current Assets	6.5M	18.9M	82.6M	43.9M	24.5M	20.8M
Common Stock	40.5K	64K	86K	95K	9K	8.6K
Non Current Assets Total	692.9K	837K	4.3M	10.1M	8.6M	9.1M
Non Currrent Assets Other	692.9K	755K	725K	1.1M	1.1M	614.4K
Other Assets	693K	837K	725K	1.1M	1.0	0.95
Non Current Liabilities Total	10.5M	300K	4.3B	1.8M	3.0M	2.8M
Noncontrolling Interest In Consolidated Entity	(161.5K)	(814.3K)	(2.4M)	17.8M	20.4M	21.4M
Retained Earnings Total Equity	(37.0M)	(53.7M)	(88.3M)	(138.9M)	(125.0M)	(118.8M)
Short Term Investments	34K	262K	2.0M	3.0M	2.7M	2.8M
Preferred Stock Total Equity	2.0M	2.3M	2.5M	2.4M	2.8M	1.9M
Property Plant Equipment	692.9K	82K	1.6M	5.5M	6.3M	6.6M
Short Long Term Debt Total	7.9M	8.1M	15.0M	36.6M	48.7M	51.2M
Net Invested Capital	2.0M	14.3M	59.2M	21.3M	(12.6M)	(12.0M)
Short Long Term Debt	7.9M	8.1M	14.7M	33.7M	44.2M	46.4M
Net Working Capital	(5.3M)	(1.0M)	75.1M	2.7M	(29.7M)	(28.2M)
Short Term Debt	7.9M	8.1M	15.0M	34.8M	45.8M	48.1M
Capital Stock	2.3M	2.6M	2.5M	2.8M	3.0M	2.8M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:

How To Invest In PAVmed

Details

Is PAVmed Stock a good investment?

Details

What is PAVmed's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.14)

Revenue Per Share

0.459

Quarterly Revenue Growth

4.898

Return On Assets

(0.80)

Return On Equity

(13.58)

The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PAVmed Historical Balance Sheet

PAVmed Inventory

512,050

About PAVmed Balance Sheet Analysis

PAVmed Balance Sheet Chart

Total Assets

Accounts Payable

Cash And Short Term Investments

PAVmed balance sheet Correlations

PAVmed Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PAVmed balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Other Stockholder Equity	+ 1.0	Capital Surpluse

Retained Earnings Total Equity	- 0.98	Common Stock Total Equity
Other Stockholder Equity	- 0.98	Retained Earnings
Retained Earnings Total Equity	- 0.97	Capital Surpluse
Property Plant Equipment	- 0.97	Retained Earnings
Total Liab	- 0.97	Retained Earnings
Capital Surpluse	- 0.97	Retained Earnings